Modern Approaches in management of Children with Acute Bronchiolitis
Alexander A. Baranov,
Leyla S. Namazova-Baranova,
Vladimir K. Tatochenko,
Irina V. Davydova,
Maia D. Bakradze,
Tatiana V. Kulichenko,
E. V. Vishnyova,
Liliya R. Selimzyanova,
Anastasia S. Polyakova,
Inga V. Artemova https://doi.org/10.15690/pf.v16i6.2071
Abstract
The experts of the Union of Pediatricians of Russia have developed up-to-date clinical guidelines on management of children with acute bronchiolitis. Around 150 million cases of bronchiolitis (11 cases per 100 infants) are registered annually, 7–13 % of all cases require hospital treatment and 1–3 % require management in intensive care unit. Almost all children of the age under 2 years old (90 %) undergone respiratory syncytial viral infection. In 20 % of them they have bronchiolitis due to various factors. This article covers the issues of epidemiology, pathogenesis, differential diagnostics, treatment based on the principles of evidence in detail.
About the Authors
Alexander A. Baranov
Central Clinical Hospital of the Russian Academy of Sciences
Russian Federation
Moscow
Russian Federation
Moscow
Leyla S. Namazova-Baranova
Central Clinical Hospital of the Russian Academy of Sciences;
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
Vladimir K. Tatochenko
National Medical Research Center of Children’s Health
Russian Federation
Moscow
Russian Federation
Moscow
Irina V. Davydova
National Medical Research Center of Children’s Health
Russian Federation
Moscow
Russian Federation
Moscow
Maia D. Bakradze
National Medical Research Center of Children’s Health
Russian Federation
Moscow
Russian Federation
Moscow
Tatiana V. Kulichenko
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
E. V. Vishnyova
Central Clinical Hospital of the Russian Academy of Sciences;
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
Liliya R. Selimzyanova
Central Clinical Hospital of the Russian Academy of Sciences;
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Moscow
Russian Federation
Moscow
Anastasia S. Polyakova
National Medical Research Center of Children’s Health
Russian Federation
Moscow
Russian Federation
Moscow
Inga V. Artemova
National Medical Research Center of Children’s Health
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Klassifikatsiya klinicheskikh form bronkholegochnykh zabolevaniy u detey. Moscow: Rossiyskoye respiratornoye obshchestvo; 2009. 18 р. (In Russ).
2. Ralston SL, Lieberthal AS, Meissner HC, et al; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474– 1502. doi: 10.1542/peds.2014-2742.
3. Paediatric Respiratory Medicine ERS Handbook. 1st Edition. Ed. Eber E., Midulla F. European Respiratory Society; 2013. 719 р.
4. Miller EK, Bugna J, Libster R, et al. Human rhinoviruses in severe respiratory disease in very low birth weight infants. Pediatrics. 2012;129(1):e60–67. doi: 10.1542/peds.2011-0583.
5. Janssen R, Bont L, Siezen CL, et al. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis. 2007;196(6):826–834. doi: 10.1086/520886.
6. Figueras-Aloy J, Carbonell-Estrany X, Quero J; IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J. 2004;23(9):815–820. doi: 10.1097/01.inf.0000136869.21397.6b.
7. Law BJ, Langley JM, Allen U, et al. The Pediatric investigators collaborative network on infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004;23(9):806–814. doi: 10.1097/01.inf.0000137568.71589.bd.
8. Stensballe LG, Kristensen K, Simoes EA, et al.; Danish RSV Data Network. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics. 2006;118(5):e1360–1368. doi: 10.1542/peds.2006-0907.
9. Ralston S, Hill V, Waters A. Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: A systematic review. Arch Pediatr Adolesc Med. 2011;165(10):951–956. doi: 10.1001/archpediatrics.2011.155.
10. Hall CB, Simőes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol. 2013;372:39–57. doi: 10.1007/978-3-642-38919-1_2.
11. Thorburn K, Harigopal S, Reddy V, et al. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax. 2006;61(7):611–615. doi: 10.1136/thx.2005.048397.
12. Duttweiler L, Nadal D, Frey B. Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis. Arch Dis Child. 2004;89(12):1155. doi: 10.1136/adc.2004.049551.
13. Tatochenko VK. Bolezni organov dykhaniya u detey: prakticheskoye rukovodstvo. New ed., suppl. Moscow: Pediatr”; 2015. 396 р. (In Russ).
14. Patrusheva YuS, Bakradze MD. Etiology and risk factors of acute viral lower respiratory tract infections in young children. Pediatric diagnostics. 2012;4(3):45–52. (In Russ).
15. Patrusheva YuS, Bakradze MD, Kulichenko TV. Diagnostics and Treatment of Acute Bronchiolitis in Children. Pediatric diagnostics. 2011;3(1):5–11. (In Russ).
16. Doan QH, Kissoon N, Dobson S, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr. 2009;154(1):91–95. doi: 10.1016/j.jpeds.2008.07.043.
17. Doan Q, Enarson P, Kissoon N, et al. Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. Cochrane Database Syst Rev. 2014;(9):CD006452. doi: 10.1002/14651858.CD006452.pub4.
18. 18. UpToDate is the only clinical decision support resource associated with improved outcomes [Internet]. UpToDate, 2019. Available from: https://www.uptodate.com/home.
19. Cordier JF, ed. Orphan Lung Diseases. Vol. 54. Chapter 5. Bronchiolitis. European Respiratory Society Monograph; 2011. Pр. 84–103.
20. Spichak TV. Postinfektsionnyy obliteriruyushchiy bronkhiolit u detey. Moscow: Nauchnyy mir; 2005. 96 р. (In Russ).
21. Spurling GK, Doust J, Del Mar CB, Eriksson L. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev. 2011;(6):CD005189. doi: 10.1002/14651858.CD005189.pub3.
22. Mazur NI, Martin n-Torres F, Baraldi E, et al.; Respiratory Syncytial Virus Network (ReSViNET). Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015;3(11):888–900. doi: 10.1016/S2213-2600(15)00255-6.
23. Okazaniye statsionarnoy pomoshchi detyam. Rukovodstvo po lecheniyu naiboleye rasprostranennykh bolezney u detey: karmannyy spravochnik. 2nd ed. Moscow: WHO; 2013. 452 р. (In Russ).
24. Caffrey OE, Clarke JR. NICE clinical guideline: bronchiolitis in children. Arch Dis Child Educ Pract Ed. 2016;101(1):46–48. doi: 10.1136/archdischild-2015-309156.
25. Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;(6):CD001266. doi: 10.1002/14651858.CD001266.pub4.
26. Wu S, Baker C, Lang ME, et al. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial. JAMA Pediatr. 2014;168(7):657–663. doi: 10.1001/jamapediatrics.2014.301.
27. Chen YJ, Lee WL, Wang CM, Chou HH. Nebulized hypertonic saline treatment reduces both rate and duration of hospitalization for acute bronchiolitis in infants: an updated meta-analysis. Pediatr Neonatol. 2014;55(6):431–438. doi: 10.1016/j.pedneo.2013.09.013.
28. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2017;12:CD006458. doi: 10.1002/14651858.CD006458.pub4.
29. Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013;(6):CD004878. doi: 10.1002/14651858.CD004878.pub4.
30. Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013;(6):CD004878. doi: 10.1002/14651858. CD004878.pub4.
31. Roqué FM, Giné-Garriga M, Granados RC, et al. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2016;2:CD004873. doi: 10.1002/14651858.CD004873.pub5.
32. Nishimura T, Suzue J, Kaji H. Breastfeeding reduces the severity of respiratory syncytial virus infection among young infants: a multicenter prospective study. Pediatr Int. 2009;51(6):812–816. doi: 10.1111/j.1442-200X.2009.02877.x.
33. Dornelles CT, Piva JP, Marostica PJ. Nutritional status, breastfeeding, and evolution of infants with acute viral bronchiolitis. J Health Popul Nutr. 2007;25(3):336–343.
34. Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997;52(10):905–914. doi: 10.1136/thx.52.10.905.
35. Jones LL, Hashim A, McKeever T, et al. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and metaanalysis. Respir Res. 2011;12:5. doi: 10.1186/1465-9921-12-5.
36. Bradley JP, Bacharier LB, Bonfiglio J, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics. 2005;115(1):e7–14. doi: 10.1542/peds.2004-0059.
37. Al-Shawwa B, Al-Huniti N, Weinberger M, Abu-Hasan M. Clinical and therapeutic variables influencing hospitalisation for bronchiolitis in a community-based paediatric group practice. Prim Care Respir J. 2007;16(2):93–97. doi: 10.3132/pcrj.2007.00018.
38. Hall CB. Nosocomial respiratory syncytial virus infections: the “Cold War” has not ended. Clin Infect Dis. 2000;31(2): 590–596. doi: 10.1086/313960.
39. Hall CB, Douglas RG Jr, Geiman JM. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis. 1980;141(1):98– 102. doi: 10.1093/infdis/141.1.98.
40. Sattar SA, Springthorpe VS, Tetro J, et al. Hygienic hand antiseptics: should they not have activity and label claims against viruses? Am J Infect Control. 2002;30(6):355–372. doi: 10.1067/mic.2002.124532.
41. Picheansathian W. A systematic review on the effectiveness of alcohol-based solutions for hand hygiene. Int J Nurs Pract. 2004;10(1):3–9. doi: 10.1111/j.1440-172x.2003.00457.x.
42. American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134(2):e620– 638. doi: 10.1542/peds.2014-1666.
43. Baranov AA, Ivanov DO, Alyamovskaya GA, et al. Palivizumab: four seasons in Russia. Annals of the Russian Academy of Medical Sciences. 2014;69(7-8):54–68. (In Russ). doi: 10.15690/vramn.v69i78.1110.
Review
For citations:
Baranov A.A., Namazova-Baranova L.S., Tatochenko V.K., Davydova I.V., Bakradze M.D., Kulichenko T.V., Vishnyova E.V., Selimzyanova L.R., Polyakova A.S., Artemova I.V. Modern Approaches in management of Children with Acute Bronchiolitis. Pediatric pharmacology. 2019;16(6):339-348. (In Russ.) https://doi.org/10.15690/pf.v16i6.2071
Views:
1111
Email this article 